INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Disposable DNA diagnostic sensors from MIT stay accurate for two months at 150 °F, cutting test costs to 50¢ and removing ...

The UK government has finally unveiled its much-anticipated ten-year Plan for improving England's health. It contains a ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

LX2006 also selected for FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot (CDRP) program, created to facilitate CMC registrational readiness and support faster patient access ...

In a landmark gathering that placed lived experience at the center of global health discourse, the 3rd Global Forum of ...

HHS Secretary Robert F. Kennedy Jr. was on The Tucker Carlson Show last week. It got me to thinking: What's next in RFK Jr.'s ...